The variety and quality of our growing collection of bioconjugated antibodies, together with the dissemination of our research through scientific publications, patents and technology offers, has sparked the interest of national and international research groups, sectoral bodies, and companies producing and marketing bioanalytical kits — opening channels for collaboration and technology transfer.

Scientific collaborations established across several countries to evaluate our conjugates and antibodies in different systems and to assess their implementation on a range of analytical platforms.